Literature DB >> 28652256

Fundamental Cardiovascular Research: Returns on Societal Investment: A Scientific Statement From the American Heart Association.

Joseph A Hill, Reza Ardehali, Kimberli Taylor Clarke, Gregory J Del Zoppo, Lee L Eckhardt, Kathy K Griendling, Peter Libby, Dan M Roden, Hesham A Sadek, Christine E Seidman, Douglas E Vaughan.   

Abstract

Recent decades have witnessed robust successes in conquering the acutely lethal manifestations of heart and vascular diseases. Many patients who previously would have died now survive. Lifesaving successes like these provide a tremendous and easily recognized benefit to individuals and society. Although cardiovascular mortality has declined, the devastating impact of chronic heart disease and comorbidities on quality of life and healthcare resources continues unabated. Future strides, extending those made in recent decades, will require continued research into mechanisms underlying disease prevention, pathogenesis, progression, and therapeutic intervention. However, severe financial constraints currently jeopardize these efforts. To chart a path for the future, this report analyzes the challenges and opportunities we face in continuing the battle against cardiovascular disease and highlights the return on societal investment afforded by fundamental cardiovascular research.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  AHA Scientific Statements; discovery science; drug discovery; heart disease; research (or laboratory research)

Mesh:

Year:  2017        PMID: 28652256     DOI: 10.1161/RES.0000000000000155

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  1 in total

Review 1.  Exercise limitations in heart failure with reduced and preserved ejection fraction.

Authors:  David C Poole; Russell S Richardson; Mark J Haykowsky; Daniel M Hirai; Timothy I Musch
Journal:  J Appl Physiol (1985)       Date:  2017-10-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.